300622 博士眼镜
2026/09 - 九个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入1,170,1978.30%1,360,3831,202,8161,175,865962,237
减:营业总成本1,027,3295.24%1,186,1441,071,9841,016,777880,745
    其中:营业成本507,4261.56%536,413460,536434,227367,214
               财务费用12,542119.81%8,1967,9194,7219,518
               资产减值损失(5,010)355.98%(15,881)(21,226)(9,999)(4,440)
公允价值变动收益29,158569.36%24,3902,2094,579(832)
投资收益4,177-32.80%8,03010,6168,9246,852
    其中:对联营企业和合营企业的投资收益0-89.42%4------
营业利润174,25952.03%193,527130,071166,73190,943
利润总额173,91252.50%191,988129,116164,12592,839
减:所得税费用38,12069.76%38,29827,79932,37018,400
净利润135,79248.27%153,690101,317131,75574,439
减:非控股权益4,71925.75%5,084(2,311)3,690(1,371)
股东净利润131,07349.23%148,606103,628128,06575,810

市场价值指针
每股收益 (元) *0.41046.43%0.6500.4600.7400.450
每股派息 (元) *0.240--0.2700.2700.6000.300
每股净资产 (元) *2.896-22.18%3.9864.3404.5303.947
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容